IAG Capital Partners

Activity from announced rounds

Activity in this selectionOct 20, 2026 · Jul 23, 2026

IAG Capital Partners is the Charleston investment firm identified in its own Xscape portfolio and investment announcement.

Recorded funding activity

The recorded activity includes Arcee’s open-weight models, ReEmerge’s therapy for chronic cognitive impairment and Cornelis’ high-speed computing-network fabrics. The full firm identity distinguishes it from unrelated angel and airline organizations using IAG.

Sources
Rounds participated in
5
Confirmed lead rounds
1
All roles disclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$92M
2 disclosed · full round size, not this investor’s share

By stage

Series A2
Series B1
Series C+1
Undisclosed1

By primary sector

AI2
Healthtech2
Hardware1

By country

United States4
United Kingdom1

Rounds

5 in this selection
Universal Quantum

Modular trapped-ion quantum computers built by connecting small quantum chips.

>$100MSeries A
Participant
Arcee AI

Open-weight language models and deployment tools that let organizations adapt and run AI on infrastructure they control.

≥$150MSeries B
Participant
ReEmerge, Inc.

ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.

$37MSeries A
Participant
Cornelis Networks

High-speed network fabrics that connect GPUs and CPUs in AI and high-performance computing clusters, helping keep accelerators productive as workloads exchange data.

~$205MFunding round
Lead
Elucid

Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.

$55MSeries D
Participant